PARP Inhibitors Market Size, Share, Growth and Forecast (2024-2032) | UnivDatos
According to a new report by Univdatos Market Insights, PARP Inhibitors Market, is expected to reach USD 13835 Million in 2032 by growing at a CAGR of 12.9%. PARP (Poly (ADP-ribose) polymerase) inhibitors are a class of medications that interfere with the actions of PARP enzymes in cells. These enzymes are involved in DNA repair, particularly in the repair of single-strand DNA breaks. By...
0 Σχόλια 0 Μοιράστηκε 56 Views